If you need more lookups,
subscriptions start at $34 USD/month.
Mary King Location
United States
Mary King Work
Executive Director, Pipeline and Portfolio @ (September 2025 - Present)
Remibrutinib Lifecycle Lead @ (April 2024 - August 2025)
VP, Head of Strategy @ (November 2022 - April 2024)
Principal @ Commonwealth Consulting (January 2018 - November 2022)
Senior Director, Global Mktg, Lilly Diabetes, Trulicity, New Product Planning and Brand Development @ Eli Lilly and Company (January 2014 - December 2017)
Senior Director, Global Marketing, Lilly Diabetes, Trulicity and New Product Planning (Portfolio) @ Eli Lilly and Company (January 2011 - December 2014)
Senior Director for Global Diabetes Marketing, New Product Planning @ Eli Lilly and Company (January 2010 - December 2011)
Board Member @ IndyHumane (January 2010 - December 2014)
Director of Global Marketing, Dulaglutide (GLP Fc) @ Eli Lilly and Company (January 2006 - December 2010)
Sales Supervisor, US Affiliate Sales Force @ Eli Lilly and Company (January 2004 - December 2006)
Director of Global Marketing, Xigris @ Eli Lilly and Company (January 2001 - December 2004)
Manager, Endocrine Global Market Research @ Eli Lilly and Company (January 1998 - December 2001)
Principal @ Commonwealth Consulting
Manager, Regulatory Quality Systems @ Eli Lilly and Company (January 1996 - December 1998)
Manager, Regulatory Strategic Planning @ Eli Lilly and Company (January 1995 - December 1996)
Associate roles in Finance, Economic Studies and Information Technology @ Eli Lilly and Company (January 1986 - December 1990)
Mary King Education
Harvard Business School
MBA (Business)
1990-1992
Miami University
BS (Finance)
1982-1986
Mary King Skills
Global Marketing
Pharmaceutical Industry
Product Launch
Diabetes
Sales Effectiveness
Pharmaceutical Sales
Commercialization
Competitive Intelligence
Neurology
Market Analysis
Clinical Trials
Cross-functional Team Leadership
Endocrinology
Biotechnology
Marketing Management
Cardiology
Hospital Sales
Segmentation
Marketing Strategy
Managed Care
Urology
Clinical Development
Strategy
Market Access
FDA
Market Research
Lifesciences
Market Planning
Leadership
Accounting
Business Analysis
Marketing
Cross Functional Team Leadership
Marketing Communications
Dec Alpha
Cardiovascular Disease
GLP
Product Placement
Consulting
Space
Pennsylvania
R&d
Initiation
Differentiation
Advisory Boards
Shares
Financial Systems
Guiding
Competitive Landscape
Insulin
Packaging
Miami
Collaborative
Sales
Promise
Conferences
Pipelines
Strategic Marketing
Adaptive
Cardiac
Safety
Kidney
Asset Allocation
Quality System
Critical Success Factors
Microsoft Excel
Therapeutic Area
Business Administration
Project Planning
Efficacy
Ovation
Responsibility
Golang
Negotiation
Messaging
Obesity
Market Share
Decision Making
Chicago
Recognizing
Financial Reporting
Device Development
Labels
Encompassing
Biologics
Payer
Country
Self Directed Work Teams
Strategies
Assessment
Design
Branding
Portfolio Management
Business Development
Science
Market
Strategic Planning
Net
Clinical Research
Investments
Patient
Research
Evidence
Networking
Phase
Business Alignment
Reimbursement
Regulators
Brand Development
Pen
Target Identification
Profiles
Endocrine
Templates
Rules
Positioning
Commercial Planning
Linking
Disclosures
Manufacturing
Asset
Retirement
Injectable
Outstanding Leadership
Fibre Channel
Pacemakers
Vascular
Project Leadership
Meetings
Campaigns
Rolling
Summa Cum Laude
Management
Scientific
Archetypes
Context
Risk Management
Simplicity
Product Development
Quotas
Brand Strategy
Disease
Selling
Customer Experience
Partnerships
Medicine
Regulations
Coaching
Phase 2
Cardiovascular
Entry
Commercial Real Estate
Healthcare
Auditing
Boston
Business Case
Indiana
Portfolio
Seamless
Pharmaceutics
Medical Devices
Biopharmaceuticals
Market Development
Mary King Summary
Mary King, based in United States, is currently a Executive Director, Pipeline and Portfolio at Novartis. Mary King brings experience from previous roles at Novartis, Avalere Health, Commonwealth Consulting and Eli Lilly and Company. Mary King holds a 1990 - 1992 MBA in Business @ Harvard Business School. With a robust skill set that includes Global Marketing, Pharmaceutical Industry, Product Launch, Diabetes, Sales Effectiveness and more. Mary King has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Mary King?
Find contact details for 700 million professionals.